ELIZABETH SHPALL to Sirolimus
This is a "connection" page, showing publications ELIZABETH SHPALL has written about Sirolimus.
Connection Strength
0.171
-
Safety and Efficacy of Vorinostat Plus Sirolimus or Everolimus in Patients with Relapsed Refractory Hodgkin Lymphoma. Clin Cancer Res. 2020 11 01; 26(21):5579-5587.
Score: 0.132
-
Activated B cells suppress T-cell function through metabolic competition. J Immunother Cancer. 2022 12; 10(12).
Score: 0.038